Phase 3 study is expected to be substantially funded ... Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Icon PLC, the Irish-headquartered clinical research giant, has warned the markets that a large Covid-19 vaccine study it recently told investors about was delayed by its sponsor. In February, CEO ...

2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage ...

Key Insights Significantly high institutional ownership implies Legal & General Group's stock price is sensitive ...

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP ...

The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine hesitancy, according to the Washington Post, even though the Texas measles ...

Satellites come in all shapes and sizes, but there aren't any that look quite like SPHEREx, an infrared observatory NASA ...

With their music continuing to entertain fans all over the world, Pearson recently passed away at 60 years old. Dealing with several health issues over the recent years, Pearson suffered from diabetes ...

Receiving an electronic reminder about influenza vaccination appeared to decrease COVID vaccination rates. Further study of ...

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint ...